SecBot SecBot
8-K ·Filed Apr 20, 2026

WLKP

Westlake Chemical Partners LP
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001193125-26-164239
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Monitor upcoming 10-Q or earnings call for commentary on integration plans or strategic direction under new CFO. No immediate trading implications, but assess investor sentiment on leadership continuity.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
WLKP ▼ -2.42% at T+60d
NEUTRAL call -2.42% · α vs SPY -9.32% · entry $22.33 → $21.79
Entry = T+0 close
Apr 20, 2026
via day close
T+1d
+0.58%
call +0.58% · α -0.44%
$22.46
settled 6mo ago
T+5d
+2.19%
call +2.19% · α +1.11%
$22.82
settled 6mo ago
T+20d
+1.70%
call +1.70% · α -3.21%
$22.71
settled 5mo ago
T+60d
-2.42%
call -2.42% · α -9.32%
$21.79
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Westlake Chemical Partners LP announced the appointment of Jonathan H. Baksht as Senior Vice President, Chief Financial Officer, and director of its general partner, effective June 15, 2026. He succeeds M. Steven Bender, who will retire and transition to a special advisory role. The move represents a planned leadership transition with a seasoned executive from Fortune Brands Innovations and Pactiv Evergreen.

Key Facts

  • Jonathan H. Baksht appointed as Senior Vice President and CFO of Westlake Chemical Partners GP LLC, effective June 15, 2026
  • Baksht also joins the Board of Directors of the general partner
  • He succeeds M. Steven Bender, who retires by year-end and transitions to Special Advisor to the President
  • Baksht previously served as CFO at Fortune Brands Innovations (May 2025–March 2026) and Pactiv Evergreen (May 2022–May 2025)
  • No family or transactional relationships disclosed between Baksht and current officers or directors

Financial Impact

No immediate financial impact disclosed; leadership transition is planned and orderly

executive leadershipgovernance

Risk Factors

  • Execution risk during CFO transition period
  • Potential for strategic shift under new financial leadership

Market Snapshot

Exchange
NYSE
Sector
Industrial Organic Chemicals

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-164239
Document: d33835dex991.htm0001193125-26-164239
Document: 0001193125-26-164239-index-headers.html0001193125-26-164239
Document: 0001193125-26-164239-index.html0001193125-26-164239
Document: 0001193125-26-164239.txt0001193125-26-164239
4 reports for WLKP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for WLKP — sortable, filterable
TypeNow
Aug 31, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$21.73awaiting T+60—$21.15 (−2.67%)
Aug 4, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$21.30awaiting T+60—$21.15 (−0.70%)
May 5, 2026
24w ago
8-K
BULLISH ★ 6/10
$22.57 $21.73▼ −3.72%▼ −6.46%$21.15 (−6.29%)
Apr 20, 2026
27w ago
8-K
NEUTRAL ★ 3/10
$22.33 $21.79▼ −2.42%▼ −9.32%$21.15 (−5.28%)
Showing 4 of 4

US Market Status

Market Closed — Opens Wed (12h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026